betulinic acid has been researched along with formazans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, T; Gotoh, K; Kanamoto, T; Kanbara, K; Kashiwada, Y; Nakashima, H; Sano, K; Yoshimori, M | 1 |
| Gupta, S; Rabi, T; Shukla, S | 1 |
2 other study(ies) available for betulinic acid and formazans
| Article | Year |
|---|---|
Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation.
Topics: Anti-HIV Agents; Betulinic Acid; Cell Fusion; Formazans; Giant Cells; HIV-1; Humans; Microbial Sensitivity Tests; Pentacyclic Triterpenes; Tetrazolium Salts; Time Factors; Triterpenes; Tumor Cells, Cultured; Viral Proteins; Virion | 2001 |
Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Formazans; Genes, Reporter; Humans; Luciferases; Male; NF-kappa B; Pentacyclic Triterpenes; Prostatic Neoplasms; Tetrazolium Salts; Time Factors; Transfection; Triterpenes; Tumor Necrosis Factor-alpha | 2008 |